Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:42 PM
Ignite Modification Date:
2025-12-24 @ 1:42 PM
NCT ID:
NCT02068495
Eligibility Criteria:
Inclusion Criteria:
1\. Participants with hypertension
Exclusion Criteria:
1. Participants in whom Candesartan cilexetil/Amlodipine besilate is contraindicated \[Contraindications\]
2. Participants with a history of hypersensitivity to the ingredients of Candesartan cilexetil/Amlodipine besilate or any other dihydropyridine formulations
3. Women who are pregnant or of child-bearing potential
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02068495
Study Brief:
Protocol Section:
NCT02068495